Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents, and young adults (BREATHER): a randomised, open-label, non-inferiority, phase 2/3 trial. (2016)
Attributed to:
Paediatric and adolescent infections
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2352-3018(16)30054-6
PubMed Identifier: 27562743
Publication URI: http://europepmc.org/abstract/MED/27562743
Type: Journal Article/Review
Volume: 3
Parent Publication: The lancet. HIV
Issue: 9
ISSN: 2352-3018